This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Lawrence Wee
Director, Data Scientist & Innovation at Allianz Asia Pacific


Dr. Lawrence Wee is a data science practitioner and innovator in healthcare and insurance. At Allianz Asia-Pacific he provides healthcare data science thought leadership and drives regional innovation efforts at the intersection of data, health and insurance.

Prior to this role, he founded the healthcare and biomedical analytics laboratory at the Institute of Infocomm Research (I2R) in Singapore, and served as principal investigator for research initiatives in genomics, precision medicine, digital health and population health. After the stint at I2R, he moved on to Zuellig Pharma where he took on the role of Chief Data Scientist and led the development of healthcare data capabilities for pharma stakeholders.

Dr. Wee sits on the scientific advisory boards of several technology companies in cybersecurity, medtech and healthtech, and speaks regularly at international conferences in artificial intelligence, data and healthcare. He was previously the President of the Association for Medical and Bio-informatics Singapore (AMBIS), and the current vice-chair of the Chinese-American Pharmaceutical Society (CABS) Singapore chapter. He received his Ph.D. in Computational Biology and Machine Learning from the National University of Singapore. He is also an Associate Faculty at the Singapore University of Social Sciences, and runs a research program in artificial intelligence for cancer genetics.

Agenda Sessions

  • Strategy Roundtable: Which New Technologies - DLT; AI; Cloud; Quantum; Data Analytics; Cryptography & Biometrics - Will Transform Financial Crime Management? Why COVID 19 Will Put Digital Identity At The Top Of The Agenda